 |
1 Disease |  |
1 Trial |
|
1 Trial |  |
79 News |  |
- ||| Buventol Easyhaler (salbutamol dry-powder inhaler) / Orion Corp, Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Trial completion: EASYRELIEF: Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing (clinicaltrials.gov) - Sep 5, 2023
P4, N=180, Completed, Sponsor: Orion Corporation, Orion Pharma
Recruiting --> Completed
- | Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Journal: The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions. (Pubmed Central) - Feb 24, 2023
Recruiting --> Completed The relative increase in the emitted dose varied between 0.2 and 8.0% (min: Foster
- || Buventol Easyhaler (salbutamol dry-powder inhaler) / Orion Corp, Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Trial completion date, Trial primary completion date: EASYRELIEF: Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing (clinicaltrials.gov) - Oct 27, 2022
P4, N=180, Recruiting, Sponsor: Orion Corporation, Orion Pharma
The relative increase in the emitted dose varied between 0.2 and 8.0% (min: Foster Trial completion date: Sep 2022 --> May 2023 | Trial primary completion date: Sep 2022 --> May 2023
- ||| Buventol Easyhaler (salbutamol dry-powder inhaler) / Orion Corp, Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Enrollment open: EASYRELIEF: Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing (clinicaltrials.gov) - Feb 18, 2022
P4, N=180, Recruiting, Sponsor: Orion Corporation, Orion Pharma
Trial completion date: Sep 2022 --> May 2023 | Trial primary completion date: Sep 2022 --> May 2023 Not yet recruiting --> Recruiting
- |||| Buventol Easyhaler (salbutamol dry-powder inhaler) / Orion Corp, Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
New P4 trial: EASYRELIEF: Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing (clinicaltrials.gov) - Oct 19, 2021
P4, N=180, Not yet recruiting, Sponsor: Orion Corporation, Orion Pharma
- Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: BufoSwitch: Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway (clinicaltrials.gov) - Sep 23, 2021
P=N/A, N=29, Terminated, Sponsor: Orion Corporation, Orion Pharma
Not yet recruiting --> Recruiting N=1000 --> 29 | Trial completion date: Dec 2021 --> Sep 2021 | Recruiting --> Terminated | Trial primary completion date: Dec 2021 --> Sep 2021; Target recruitment not reached
- || Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Trial completion date, Trial primary completion date: BufoSwitch: Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway (clinicaltrials.gov) - Aug 18, 2021
P=N/A, N=1000, Recruiting, Sponsor: Orion Corporation, Orion Pharma
N=1000 --> 29 | Trial completion date: Dec 2021 --> Sep 2021 | Recruiting --> Terminated | Trial primary completion date: Dec 2021 --> Sep 2021; Target recruitment not reached Trial completion date: Apr 2021 --> Dec 2021 | Trial primary completion date: Apr 2021 --> Dec 2021
- ||| Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Enrollment open: BufoSwitch: Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway (clinicaltrials.gov) - Feb 24, 2021
P=N/A, N=1000, Recruiting, Sponsor: Orion Corporation, Orion Pharma
Trial completion date: Apr 2021 --> Dec 2021 | Trial primary completion date: Apr 2021 --> Dec 2021 Not yet recruiting --> Recruiting
- |||||| Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
New trial: BufoSwitch: Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway (clinicaltrials.gov) - Dec 11, 2020
P, N=1000, Not yet recruiting, Sponsor: Orion Corporation, Orion Pharma
- | Easyhaler (budesonide/formoterol dry powder inhalers) / Orion
Si el enfermo tiene flujos inspiratorios bajos funcionan mejor dispositivos de alta resistencia que dishomogenicen bien las partículas por ejemplo #easyhaler @OrionPharma @menarini_es o #handihaler @Boehringer Puede verse en la imagen de @J_AlejandroMD (Twitter) - Oct 21, 2019
- | Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
New P1 trial: Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler (clinicaltrials.gov) - Mar 8, 2017
P1, N=20, Completed, Sponsor: Orion Corporation, Orion Pharma
- ||||||| Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Trial completion: BUFODIL: To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product (clinicaltrials.gov) - Jun 30, 2015
P3, N=72, Completed, Sponsor: Orion Corporation, Orion Pharma
Not yet recruiting --> Recruiting Recruiting --> Completed
- |||||| Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Enrollment open: BUFODIL: To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product (clinicaltrials.gov) - Jan 3, 2015
P3, N=72, Recruiting, Sponsor: Orion Corporation, Orion Pharma
Recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
New P3 trial: BUFODIL: To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product (clinicaltrials.gov) - Dec 5, 2014
P3, N=72, Not yet recruiting, Sponsor: Orion Corporation, Orion Pharma
- | Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Trial completion: REFLI: Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (clinicaltrials.gov) - Nov 21, 2012
P1, N=48, Completed, Sponsor: Orion Corporation, Orion Pharma
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Trial completion: Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler (clinicaltrials.gov) - Nov 20, 2012
P1, N=72, Completed, Sponsor: Orion Corporation, Orion Pharma
Recruiting --> Completed Active, not recruiting --> Completed
- ||| Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Trial completion: ADECO: Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte (clinicaltrials.gov) - Oct 11, 2012
P1, N=72, Completed, Sponsor: Orion Corporation, Orion Pharma
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
New P1 trial: REFLI: Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (clinicaltrials.gov) - Aug 15, 2012
P1, N=48, Completed, Sponsor: Orion Corporation, Orion Pharma
- ||| Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
New P1 trial: ADECO: Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte (clinicaltrials.gov) - Jun 21, 2012
P1, N=72, Completed, Sponsor: Orion Corporation, Orion Pharma
- ||| Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
New P1 trial: Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler (clinicaltrials.gov) - May 6, 2012
P1, N=72, Completed, Sponsor: Orion Corporation, Orion Pharma
- | Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Trial completion: Pharmacokinetic Pilot Study on Budesonide/Formoterol (clinicaltrials.gov) - Feb 1, 2012
P=N/A, N=17, Completed, Sponsor: Orion Corporation, Orion Pharma
Active, not recruiting --> Completed Recruiting --> Completed
- ||| Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Trial completion: Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler (clinicaltrials.gov) - Dec 20, 2011
P1, N=74, Completed, Sponsor: Orion Corporation, Orion Pharma
Recruiting --> Completed Not yet recruiting --> Completed
- | Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
Trial completion: Phase I Pharmacokinetic Study (BF-BLOCK) (clinicaltrials.gov) - Oct 19, 2011
P1, N=20, Completed, Sponsor: Orion Corporation, Orion Pharma
Not yet recruiting --> Completed Recruiting --> Completed
- | Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
New P1 trial: Phase I Pharmacokinetic Study (BF-BLOCK) (clinicaltrials.gov) - Aug 22, 2011
P1, N=20, Completed, Sponsor: Orion Corporation, Orion Pharma